AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
9.61
-0.03 (-0.31%)
Apr 25, 2025, 4:00 PM EDT - Market closed
AngioDynamics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for AngioDynamics stock have an average target of 14, with a low estimate of 12 and a high estimate of 16. The average target predicts an increase of 45.68% from the current stock price of 9.61.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AngioDynamics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $16 | Strong Buy | Maintains | $15 → $16 | +66.49% | Apr 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $15 | Strong Buy | Maintains | $14 → $15 | +56.09% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +45.68% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +45.68% | Oct 4, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 → $12 | Strong Buy | Maintains | $13 → $12 | +24.87% | Oct 4, 2024 |
Financial Forecast
Revenue This Year
292.38M
from 303.91M
Decreased by -3.80%
Revenue Next Year
310.96M
from 292.38M
Increased by 6.35%
EPS This Year
-0.30
from -4.59
EPS Next Year
-0.23
from -0.30
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 301.7M | 324.4M | 343.7M | ||
| Avg | 292.4M | 311.0M | 333.8M | ||
| Low | 280.1M | 296.5M | 320.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.7% | 10.9% | 10.5% | ||
| Avg | -3.8% | 6.4% | 7.4% | ||
| Low | -7.8% | 1.4% | 3.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.30 | -0.21 | 0.09 | ||
| Avg | -0.30 | -0.23 | 0.09 | ||
| Low | -0.28 | -0.27 | 0.09 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.